Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 15 of 15 entries
View as:
Phase: N/A
Priority: Normal
Start: 10/31/24
End: 02/28/29
Due: 02/28/30
Phase: N/A
Priority: Normal
Start: 01/24/19
End: 08/30/22
Due: 08/30/23
Phase: N/A
Priority: Normal
Start: 06/30/13
End: 02/29/16
Due: 02/28/17
Phase: N/A
Priority: Normal
Start: 11/28/18
End: 10/30/20
Due: 10/30/21
Phase: N/A
Priority: Normal
Start: 03/07/25
End: 08/31/27
Due: 08/31/28
Phase: N/A
Priority: Normal
Start: 05/28/18
End: 09/22/22
Due: 09/22/23
Phase: N/A
Priority: Normal
Start: 09/30/09
End: 12/31/10
Due: 12/31/11
Phase: N/A
Priority: Normal
Start: 01/26/22
End: 02/22/23
Due: 02/22/24
Phase: N/A
Priority: Normal
Start: 12/31/08
End: 10/31/12
Due: 10/31/13
Phase: N/A
Priority: Normal
Start: 09/07/21
End: 06/30/27
Due: 06/30/28
Phase: N/A
Priority: Normal
Start: 07/31/08
End: 11/30/12
Due: 11/30/13
Clinical Trial to Evaluate the Safety, Tolerability and Efficacy of CT303 in Patients With Psoriasis
Phase: N/A
Priority: Normal
Start: 10/25/21
End: 12/30/24
Due: 12/30/25
Phase: N/A
Priority: Normal
Start: 09/30/24
End: 07/30/25
Due: 07/30/26
Phase: N/A
Priority: Normal
Start: 11/28/16
End: 09/17/19
Due: 09/17/20
Phase: N/A
Priority: Normal
Start: 12/31/13
End: 07/04/17
Due: 07/04/18